Saltar al contenido
Merck

HPLC Analysis of Paclitaxel and Related Compounds on Ascentis® Express F5

HPLC Analysis of Paclitaxel and Related Compounds on Ascentis® Express F5 application for HPLC

Materiales

analytical column

Referencia del producto
Descripción
Precios

Ascentis® Express F5, 5 μm HPLC Column

5 μm particle size, L × I.D. 15 cm × 4.6 mm

standard

Referencia del producto
Descripción
Precios

Baccatin III

≥95% (HPLC)

Paclitaxel

from Taxus yannanensis, powder

Cephalomannine

≥97% (HPLC), solid

CONDITIONS

column

Ascentis Express F5, 15 cm x 4.6 mm I.D., 5 μm particles (50631-U)

mobile phase

[A] water; [B] acetonitrile; (60:40, A:B)

flow rate

1.5 mL/min

pressure

2727 psi (188 bar)

column temp.

30 °C

detector

UV, 227 nm

injection

5 μL

sample

taxols 25 μg/mL in 70:15:15, water:methanol:acetonitrile

Descripción

Analysis Note

An efficient reverse phase HPLC method for the HPLC analysis of of Paclitaxel (Taxol) and related compounds is developed using the Ascentis® Express F5 5μm Fused Core HPLC column. Paclitaxel is a natural product with antitumor activity. TAXOL (paclitaxel) is obtained via a semi-synthetic process from Taxus baccata.
The developed method can be easily used for the routine quality control of bulk and Parenterals dosage form of Paclitaxel within a short analysis time. This method offers the advantages of higher efficies, reduced backpressure and shorter run times over a traditionally run methods over 5 μm totally porous particle columns.

Legal Information

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany